Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

348
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
348
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

605
Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
605
Endocarditis I: Introduction01:25

Endocarditis I: Introduction

840
Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
840
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

330
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
330
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

864
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
864
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

498
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
498

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Management of Patients at Risk of Ischemic Stroke With Left Ventricular Systolic Dysfunction in the Absence of Intracardiac Thrombus: A Scientific Statement From the American Heart Association.

Stroke·2026
Same author

Direct oral anticoagulants versus aspirin for prevention of overt and covert cerebral infarction: A meta-analysis.

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association·2026
Same author

Prior Myocardial Infarction and Cognitive Decline: The REGARDS Cohort.

Stroke·2026
Same author

Hypertension With High-Risk Features in Cryptogenic Stroke: An Exploratory Analysis of the ARCADIA Randomized Clinical Trial.

JAMA neurology·2026
Same author

Echocardiographic wall motion abnormalities in patients with stroke may warrant cardiac evaluation.

Journal of neurology, neurosurgery, and psychiatry·2026
Same author

Trends in Intervention Modality for Hospitalizations with Infectious Intracranial Aneurysms: A Nationwide Analysis.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia·2026

Related Experiment Video

Updated: Apr 15, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

12.8K

Readmission for infective endocarditis after ischemic stroke or transient ischemic attack.

Stacy Y Chu1, Alexander E Merkler1, Natalie T Cheng1

  • 1Department of Neurology, Weill Cornell Medical College, New York, NY, USA.

The Neurohospitalist
|April 2, 2015
PubMed
Summary

The rate of missed infective endocarditis (IE) diagnoses in stroke or transient ischemic attack (TIA) patients discharged before blood culture results was negligible. This suggests routine blood cultures are not necessary for evaluating acute cerebral ischemia.

Keywords:
blood culturesinfective endocarditisstroketransient ischemic attack

More Related Videos

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
05:26

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

9.8K

Related Experiment Videos

Last Updated: Apr 15, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

12.8K
Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
05:26

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

9.8K

Area of Science:

  • Neurology
  • Infectious Diseases
  • Cardiology

Background:

  • Varying clinical practices exist regarding blood culture use in ischemic stroke and TIA patients.
  • The risk of missed infective endocarditis (IE) in these patients is a concern.

Purpose of the Study:

  • To assess the rate of missed IE diagnoses in patients discharged with stroke or TIA before blood culture results were available.
  • To inform clinical guidelines on the utility of blood cultures in acute cerebral ischemia evaluations.

Main Methods:

  • Retrospective cohort study using administrative claims data from California emergency departments and hospitals (2005-2011).
  • Included patients discharged with stroke or TIA and a length of stay <= 2 days.
  • Outcome measured was hospitalization for IE within 14 days of discharge.

Main Results:

  • Among 173,966 eligible patients, 24 were subsequently hospitalized for IE (1.4 per 10,000).
  • Factors associated with IE readmission included prosthetic valve (OR 15.8) and urinary tract infection (OR 3.5).

Conclusions:

  • The rate of subsequent IE in patients with acute cerebral ischemia discharged before blood culture results is negligible.
  • These findings do not support the routine use of blood cultures for evaluating stroke or TIA.